Surgical Science Sweden

Research Surgical Science Sweden (SUS.ST) on Bullrun: market cap SEK 2.61B, P/E 28.1. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is SEK 2.61B; P/E is 28.1.

Peer valuation comparison

Latest P/E is 28.1x versus a Healthcare sector median of 24.64x (14.1% above).

Latest P/E is 28.1x versus a Sweden median of 18.18x (54.6% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025SEK 992.34MSEK 66.82MSEK 30.45M66.3%1.31SEK 616.43MSEK 56.40MSEK 4.27B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-06SEK 2.61B28.1n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SEK.

About Surgical Science Sweden

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Surgical Science Sweden's market cap?

Surgical Science Sweden's market capitalization is SEK 2.61B.

What is Surgical Science Sweden's P/E ratio?

Surgical Science Sweden's price-to-earnings (P/E) ratio is 28.1.

What does Surgical Science Sweden do?

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally.